Literature DB >> 28265130

Interventional Therapy for Upper Extremity Deep Vein Thrombosis.

Timothy A Carlon1, Deepak Sudheendra2.   

Abstract

Approximately 10% of all deep vein thromboses occur in the upper extremity, and that number is increasing due to the use of peripherally inserted central catheters. Sequelae of upper extremity deep vein thrombosis (UEDVT) are similar to those for lower extremity deep vein thrombosis (LEDVT) and include postthrombotic syndrome and pulmonary embolism. In addition to systemic anticoagulation, there are multiple interventional treatment options for UEDVT with the potential to reduce the incidence of these sequelae. To date, there have been no randomized trials to define the optimal management strategy for patients presenting with UEDVT, so many conclusions are drawn from smaller, single-center studies or from LEDVT research. In this article, the authors describe the evidence for the currently available treatment options and an approach to a patient with acute UEDVT.

Entities:  

Keywords:  Paget-Schroetter syndrome; interventional radiology; pharmacomechanical thrombectomy; thrombolysis; upper extremity deep vein thrombosis

Year:  2017        PMID: 28265130      PMCID: PMC5334483          DOI: 10.1055/s-0036-1597764

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  41 in total

Review 1.  Phlegmasia Cerulea Dolens in the Upper Extremity: A Case Report and Systematic Review and Outcomes Analysis.

Authors:  Jacques Greenberg; Douglas A Troutman; Valeriy Shubinets; Matthew J Dougherty; Keith D Calligaro
Journal:  Vasc Endovascular Surg       Date:  2016-02-11       Impact factor: 1.089

Review 2.  Acute Paget-Schroetter syndrome: does the first rib routinely need to be removed after thrombolysis?

Authors:  Joanelle Lugo; Adam Tanious; Paul Armstrong; Martin Back; Brad Johnson; Murray Shames; Neil Moudgill; Peter Nelson; Karl A Illig
Journal:  Ann Vasc Surg       Date:  2015-05-19       Impact factor: 1.466

3.  Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.

Authors:  Sandrine Lavau-Denes; P Lacroix; A Maubon; P M Preux; D Genet; L Vénat-Bouvet; J L Labourey; J Martin; P Slaouti; N Tubiana-Mathieu
Journal:  Cancer Chemother Pharmacol       Date:  2013-05-01       Impact factor: 3.333

4.  Nonleg venous thrombosis in critically ill adults: a nested prospective cohort study.

Authors:  Francois Lamontagne; Lauralyn McIntyre; Peter Dodek; Diane Heels-Ansdell; Maureen Meade; Julia Pemberton; Yoanna Skrobik; Ian Seppelt; Nicholas E Vlahakis; John Muscedere; Graham Reece; Marlies Ostermann; Soundrie Padayachee; Jamal Alhashemi; Michael Walsh; Bradley Lewis; David Schiff; Alan Moody; Nicole Zytaruk; Martine Leblanc; Deborah J Cook
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

5.  Natural history of major venous thrombosis of the upper extremity.

Authors:  M L Tilney; H J Griffiths; E A Edwards
Journal:  Arch Surg       Date:  1970-12

Review 6.  Peripherally Inserted Central Catheter-associated Deep Vein Thrombosis: A Narrative Review.

Authors:  Nabil Fallouh; Helen M McGuirk; Scott A Flanders; Vineet Chopra
Journal:  Am J Med       Date:  2015-02-16       Impact factor: 4.965

7.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

8.  The importance of the costoclavicular space in upper limb primary deep vein thrombosis, a study with magnetic resonance imaging (MRI) technique enhanced by a blood pool agent.

Authors:  Thomas Arnhjort; Jonas Nordberg; Martin Delle; Carl-Johan Borgis; Stefan Rosfors; Gerd Lärfars
Journal:  Eur J Intern Med       Date:  2014-05-27       Impact factor: 4.487

9.  Use of the trellis device in the management of deep vein thrombosis: a retrospective single-center experience.

Authors:  Muhammad A Chaudhry; Reji Pappy; Thomas A Hennebry
Journal:  J Invasive Cardiol       Date:  2013-06       Impact factor: 2.022

10.  Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies.

Authors:  Jeffrey S Mino; Jesse R Gutnick; Rosebel Monteiro; Nancy Anzlovar; Allan E Siperstein
Journal:  Am J Surg       Date:  2014-01-04       Impact factor: 2.565

View more
  3 in total

1.  Effort Thrombosis in 2 Athletes Suspected of Musculoskeletal Injury.

Authors:  Ross Mattox; Robert J Trager; Norman W Kettner
Journal:  J Chiropr Med       Date:  2020-08-21

2.  Single-Session Treatment of Upper Extremity Deep Venous Thrombosis and Central Venous Catheter Malfunction Using the ClotTriever System.

Authors:  Siddharth Agarwal; Christopher Sosnofsky; Jamie Saum; Manu Aggarwal; Sandeep Patel
Journal:  Cureus       Date:  2020-12-14

3.  Incidence of upper extremity deep vein thrombosis in the retrosternal reconstruction after esophagectomy.

Authors:  Leo Yamada; Motonobu Saito; Hiroya Suzuki; Shotaro Mochizuki; Eisei Endo; Koji Kase; Misato Ito; Hiroshi Nakano; Naoto Yamauchi; Takuro Matsumoto; Akinao Kaneta; Yasuyuki Kanke; Hisashi Onozawa; Hiroyuki Hanayama; Hirokazu Okayama; Shotaro Fujita; Wataru Sakamoto; Yohei Watanabe; Suguru Hayase; Zenichiro Saze; Tomoyuki Momma; Shinji Ohki; Koji Kono
Journal:  BMC Surg       Date:  2022-03-09       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.